Pharmacy Updates:
12/2025 – Opioid Strategy Member Notification English / Spanish
12/2025 – Beneficiary Opioid Education English / Spanish
10/2025 – Notice of Changes to the Formulary effective 11/01/2025 (Removal of a non-D-Eligible drug: LAGEVRIO (EUA) (MOLNUPIRAVIR) 200 MG CAPSULE) English / Spanish
09/2025 – Frequently Asked Influenza (Flu) Questions: 2025-2026 Season English / Spanish
08/2025 – Recall Notice: Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter English / Spanish
08/2025 – FDA SAFETY COMMUNICATION: FDA update on the safety of IXCHIQ (chikungunya vaccine, live) English / Spanish
08/2025 – Notice of Changes to the Formulary effective 09/01/2025 (Removal of EUTHYROID {LEVOTHYROXINE} ORAL TABLETS) English / Spanish
12/2024 – Opioid Strategy Member Notification English / Spanish
12/2024 – Beneficiary Opioid Education English / Spanish
10/2024 – Frequently Asked Influenza (Flu) Questions: 2024-2025 Season English / Spanish
09/2024 – Medicare Part B Coverage of Pre-exposure Prophylaxis (PrEP) Using Antiretroviral Therapy (oral or injectable) to Prevent Human Immunodeficiency Virus (HIV) English / Spanish
04/2024 – Notice of Changes to the Formulary effective 05/01/2024 (Removal of CAPASTAT SULFATE {CAPREOMYCIN SULFATE} 1 G VIAL INJECTION) English / Spanish
11/2023 – Opioid Strategy Member Notification English / Spanish
11/2023 – Beneficiary Opioid Education English / Spanish
08/2023 – Frequently Asked Influenza (Flu) Questions: 2023-2024 Season English / Spanish
05/2023 – Notice of Changes to the Formulary effective 7/01/2023 (Removal of CAPASTAT SULFATE {CAPREOMYCIN SULFATE} 1 G VIAL INJECTION) English / Spanish
11/2022 – 2023 Opioid Management Program: Member Notification English / Spanish
08/2022 – Frequently Asked Influenza (Flu) Questions: 2022-2023 Season English / Spanish
08/2022 – Addition of TRIZIVIR 150-300 MG TABLET to the Formulary English / Spanish
06/2022 – Information on Biosimilars
Reference: What is a Biosimilar?
For more information, visit Biosimilar and Interchangeable Biologics: More Treatment Choices
12/2021 – 2022 Opioid Management Program: Member Notification English / Spanish
08/2021 – Frequently Asked Influenza (Flu) Questions: 2021-2022 Season English / Spanish
01/2021 – 2021 Opioid Drug Management Program: Member Notification English / Spanish
12/2020 – Warning on the concurrent use of Opioids and Benzodiazepines English / Spanish
12/2020 – 2021 Formulary Updates English / Spanish
08/2020 – Frequently Asked Influenza (Flu) Questions: 2020-2021 Season English / Spanish
01/2020 – Safer Use of Opioid Pain Medications English / Spanish
11/2019 – 2020 Opioid Drug Management Program: Member Notification English / Spanish
Drug news and safety alerts:
08/2025 – Recall Notice: Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling English / Spanish
07/2025 – Recall Notice: Voluntarily recalling all lots of Sucralfate Tablets USP 1 gram as a result of the closures and discontinuation of Nostrum Labs’ quality operations English / Spanish
03/2025 – Recall Notice: Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Recalled due to Increased Reports of Allergic Reactions English / Spanish
01/2025 – Recall Notice: Fentanyl Transdermal System 25 mcg/hr from Alvogen, Inc. English / Spanish
10/2024 – Recall Notice: Atovaquone Oral suspension English / Spanish
07/2024 – Recall Notice: Clonazepam ODT from Endo, Inc. English / Spanish
05/2024 – Recall Notice: Docetaxel Injection from Sagent Pharmaceuticals English / Spanish
05/2024 – Recall Notice: Buprenorphine Hydrochloride Injection CarpujectTM Units and Labetalol Hydrochloride Injection, USP CarpujectTM Units English / Spanish
04/2024 – Recall Notice: Sapropterin Powder for Oral Solution from Dr. Reddy’s Laboratories English / Spanish
03/2024 – Recall Notice: Treprostinil Injection 20mg/20mL (1mg/mL) from Par Pharmaceuticals English / Spanish
11/2023 – FDA Drug Safety Communication: Levetiracetam and Clobazam 11.28.23 English / Spanish
11/2023 – Recall Notice: Vitrakvi (larotrectinib) Oral Solution 20 mg/mL from Bayer_11.22.23 English / Spanish
10/2023 – Recall Notice: Betaxolol 10 mg tablets by KVK-Tech, Inc._10.03.23 English / Spanish
09/2023 – Recall Notice: Brexafemme 150 mg tablets by Scynexis, Inc._9.28.23 English / Spanish
09/2023 – Recall Notice: Sucralfate Oral Suspension 1g-10mL by VistaPharm_RECALL 9.22.23 English / Spanish
09/2023 – Recall Notice: Digoxin Tablets 0.125mg and Digoxin Tablets 0.25mg Due to Label Mix-Up English / Spanish
07/2023 – Recall Notice: Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) by Cipla English / Spanish
06/2023 – Recall Notice: Dronabinol Caps 2.5 mg and Ziprasidone Caps 20 mg by Harvard Drug Group-Due to Label Mix-Up English / Spanish
05/2023 – Recall Notice: Akorn All-Products Recall Due to Company Shutdown English / Spanish
04/2023 – Drug Withdrawal Notice: Hydroxyprogesterone caproate injection and MAKENA injection Important drug WITHDRAWAL notice English / Spanish
04/2023 – Recall Notice: Atovaquone Oral Suspension, USP 750mg/5mL by Camber Pharmaceuticals English / Spanish
04/2023 – Recall Notice: Readers used with the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems important Recall notice English / Spanish
03/2023 – Recall Notice: Dabigatran Etexilate Capsules, USP 75 mg and 150 mg by Ascend Laboratories English / Spanish
01/2023 – Recall Notice: Quinapril tablets by Lupin Pharmaceuticals English / Spanish
11/2022 – Recall Notice Omnipod DASH Insulin Management System’s Personal Diabetes Manager (PDM) from Insulet English / Spanish
10/2022 – Drug Recall Notice Quinapril-HCTZ 20mg/12.5mg tablets by Aurobindo English / Spanish
07/2022 – Drug Recall Notice Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100) by Mylan English / Spanish
07/2022 – Drug Recall Notice CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor by Vi-Jon English / Spanish
06/2022 – Drug Recall Notice Milk of Magnesia 2400 mg/10 mL Oral Suspension, Milk of Magnesia 2400 mg/30 mL Oral Suspension, Magnesium Hydroxide 1200 mg/Aluminum Hydroxide 1200 mg/Simethicone 120 mg per 30 mL Oral Suspension, and Magnesium Hydroxide 2400 mg/Aluminum Hydroxide 2400 mg/Simethicone 240 mg per 30 mL Oral Suspension by Plastikon English / Spanish
06/2022 – Drug Withdrawal from market notice Ukoniq 200 mg tablets English / Spanish
05/2022 – Drug Recall Notice Anagrelide Capsules, USP 0.5 mg by Teva English / Spanish
04/2022 – Drug Recall Notice Accupril 10mg, 20mg, 40 mg tabs by Pfizer English / Spanish
03/2022 – Drug Recall Notice Orphenadrine ER 100 mg tab by Sandoz Pharmaceuticals English / Spanish
01/2022 – Metformin 750 mg ER tab by Viona Pharmaceuticals English / Spanish
12/2021 – Enoxaparin Sodium 40mg/0.4 mL injection by Sandoz English / Spanish
11/2021 – Lupin Pharmaceuticals’ Irbesartan and Irbesartan-HCTZ tablets English / Spanish
11/2021 – Drug Recall Notice for one lot of GLUCAGON® Emergency Kit English / Spanish
10/2021 – Drug Recall Notice Chantix tablets – All lots English / Spanish
09/2021 – FDA Drug Safety Communication: Xeljanz/Xeljanz XR (tofacitinib), Olumiant (baricitinib) and Rinvoq (upadacitinib) English / Spanish
08/2021 – Drug Recall Notice Chantix tablets English / Spanish
07/2021 – Drug Recall Notice Metformin HCl Extended-Release Tablets, USP 750 mg English / Spanish
05/2021 – Drug Recall Notice NP Thyroid tablets English / Spanish
02/2021 – FDA Drug Safety Communication: Xeljanz, Xeljanz XR English / Spanish
02/2021 – Drug Recall Notice Enoxaparin Sodium, USP by Apotex English / Spanish
07/2020 – Drug Recall Notice Lupin Pharmaceuticals Metformin Hydrochloride ER 500 mg and 1000mg tablets English / Spanish
07/2020 – Drug Recall Notice Granule Pharmaceuticals Metformin Hydrochloride ER 750 mg tablets English / Spanish
06/2020 – Drug Recall Notice Teva Metformin Hydrochloride ER 500 mg and 750 mg tablets English / Spanish
06/2020 – Drug Recall Notice Amneal Metformin Hydrochloride ER 500 mg and 750 mg tablets English / Spanish
05/2020 – Drug Recall Notice NP Thyroid tablets English / Spanish
04/2020 – Drug Recall Notice- Tetracycline 250mg and 500mg capsules English / Spanish
04/2020 – Drug Recall Notice ALL Ranitidine and ZANTAC products English / Spanish
01/2020 – Drug Recall Notice Ranitidine capsules (Appco) English / Spanish
01/2020 – Drug Recall Notice Mirtazapine 7.5 mg tablets lot #03119002A3 (Aurobindo) English / Spanish
11/2019 – Drug Recall Notice Ranitidine tablets and syrup (Amneal) English / Spanish
11/2019 – Drug Recall Notice Ranitidine capsules, tablets and syrup (Aurobindo) English / Spanish
11/2019 – Drug Recall Notice Ranitidine capsules and syrup (Lannett and Novitium) English / Spanish
10/2019 – Drug Recall Notice Mylan’s Alprazolam products English / Spanish
10/2019 – Drug Recall Notice Dr. Reddy’s Ranitidine Products English / Spanish
10/2019 – Drug Recall Notice Sandoz Ranitidine Capsules English / Spanish
10/2019 – FDA Drug Safety Communication: Zantac (Ranitidine) English / Spanish
09/2019 – Drug Recall Notice -Natpara (Parathryoid Hormone for Injection) English / Spanish
09/2019 – FDA Drug Safety Communication: Xeljanz, Xeljanz XR English / Spanish
08/2019 – Over the Counter (OTC) recall of multiple Altaire Ophthalmic products at CVS English / Spanish
08/2019 – Drug Recall Notice Replax 40 mg tablets English / Spanish
08/2019 – Drug Recall Notice Altair Pharmaceuticals- Ophthalmics English / Spanish
05/2019 – Drug Recall Notice Losartan and Losartan HCTZ English / Spanish
05/2019 – Drug Recall Losartan English / Spanish
04/2019 – Drug Recall Notice – Losartan Legacy MFXR English / Spanish
04/2019 – Drug Recall Notice – Valsartan – English / Spanish
04/2019 – Drug Recall Notice Losartan and Losartan HCTZ English / Spanish
04/2019 – Drug Recall Notice Losartan English / Spanish
04/2019 – Drug Recall Notice Losartan HCTZ English / Spanish
01/2019 – Drug recall notice Irbesartan and Irbesartan HCTZ English / Spanish
01/2019 – Drug recall notice for losartan and losartan-containing drug products English / Spanish
H4140_RXINFO_C
Last Updated: 11/26/2025